Medpace Holdings, Inc

$581.95-$15.03 (2.52%)

Estimate

P/E

34.2

EPS

17.02

Beta

1.151

Growth

Revenue, YoY

17.24%

Net income, YoY

34.46%

FCF, YoY

18.55%

Forecast

P/E (FWD)

EPS (FWD)

18.749

About the company

Ticker

MEDP

ISIN

US58506Q1094

Country

United States of America

Sector (GICS)

Healthcare

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Frequently asked questions

What sector does Medpace Holdings, Inc (MEDP) operate in?

Medpace Holdings, Inc belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is Medpace Holdings, Inc (MEDP) current stock price?

As of the latest data, Medpace Holdings, Inc stock price is $581.95, with a previous close of $596.98. Medpace Holdings, Inc lost -$15.03 in the last trading session, representing a -2.52% loss.

What is Medpace Holdings, Inc (MEDP) current market capitalization?

Medpace Holdings, Inc market cap is approximately 16.24 billion.

What is Medpace Holdings, Inc (MEDP) Earnings Per Share (EPS)?

The trailing EPS is $17.02, and the forward EPS is $18.75.

What is Medpace Holdings, Inc (MEDP) Price-to-Earnings (P/E) ratio?

Medpace Holdings, Inc current P/E ratio is 34.19, with a forward P/E of 31.04.

What is Medpace Holdings, Inc (MEDP) EBITDA?

Medpace Holdings, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 133.83 million.

Does Medpace Holdings, Inc (MEDP) pay dividends?

No. Medpace Holdings, Inc does not pay a dividend.

How did Medpace Holdings, Inc (MEDP) perform in its most recent earnings report?

In the last report (June 30, 2026), Medpace Holdings, Inc posted an EPS surprise of 4.17% and a revenue surprise of 2.69%.

What is Medpace Holdings, Inc (MEDP) beta (volatility) score?

Medpace Holdings, Inc has a beta of 1.151, meaning its volatility is roughly in line with the market.